Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at ARS Pharmaceuticals Inc fell by 139.55m. Cash Flow from Financing totalled 6.90m or 22,996.67% of revenues. In addition the company used 59.27m for operations while cash used for investing totalled 87.18m.
Cash flow per share | -0.4652 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 2.22 |
---|---|
Tangible book value per share | 2.22 |
More ▼
Balance sheet in USDView more
Current ratio | 32.82 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼